J Korean Radiol Soc.  1996 Nov;35(5):811-817.

Chondrosarcoma: MR Imaging Findings Correlated with Pathologic Classification and Grade

Affiliations
  • 1Department of Radiology, Seoul National University College of Medicine, Korea.

Abstract

PURPOSE
To evaluate the MR imaging findings of chondrosarcomas by correlation with pathologic classificationand grade.
MATERIALS AND METHODS
We performed MR imaging-pathologic correlation of nineteen chondrosarcomas. Conventional chondrosarcomas accounted for 15 cases (grade I : 6, II : 6, III : 3) and the mesenchymal and dedifferentiated types each accounted for two. MR signal intensity (SI) of the tumor on T1- and T2-weighted images(T1WI and T2WI, respectively), was classified as homogeneous or heterogeneous low-, iso- or high SI, and enhancing pattern as marginal, marginal and septal, marginal and nodular, or diffuse enhancement.
RESULTS
Eighteen cases of chondrosarcomas (95%) showed homogeneous or heterogeneous low- or iso SI on T1WI and high SI on T2WI. Low gradeconventional chondrosarcomas showed marginal and septal (n=8/10) or marginal (n=2/10) enhancement on Gd-enhanced MR images. Grade III conventional chondrosarcomas showed marginal or marginal and nodular enhancement. Dedifferentiated and mesenchymal chondrosarcomas showed marginal and nodular or diffuse enhancement.
CONCLUSION
Chondrosarcomas showed iso- or low SI on T1WI and high SI on T2WI. Marginal and septal enhancement was demonstrated on Gd-enhanced MR images of grade I and II conventional chondrosarcomas. If a tumor showed amarginal and nodular or diffuse enhancing pattern, this suggested it was a of high grade chondrosarcoma.

Keyword

Bone neoplasms, MR; Cartilage, MR; Gadolinium

MeSH Terms

Chondrosarcoma*
Chondrosarcoma, Mesenchymal
Classification*
Gadolinium
Magnetic Resonance Imaging*
Gadolinium
Full Text Links
  • JKRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr